SD Biosensor, Inc. (KRX:137310)

Market Cap	782.31B -43.1%
Revenue (ttm)	718.78B +2.2%
Net Income	-470.73B
EPS	-3,934.15
Shares Out	119.62M
PE Ratio	n/a
Forward PE	n/a
Dividend	200.00 (3.12%)
Ex-Dividend Date	Mar 30, 2026

Volume	85,929
Open	6,370.00
Previous Close	6,410.00
Day's Range	6,160.00 - 6,670.00
52-Week Range	5,850.00 - 10,930.00
Beta	0.69
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 13, 2026

About SD Biosensor

SD Biosensor, Inc., together with its subsidiaries, operates as an in-vitro diagnostic company in South Korea, India, Asia, Europe, the Americas, and Africa. The company offers STANDARD Q, which provides rapid diagnostic products; STANDARD F, a fluorescence immunodiagnostic system for various qualitative and quantitative diagnosis items; STANDARD E, an enzyme immunoassay diagnosis for large-volume tests; and STANDARD M, a field molecular diagnosis system for infectious disease diagnosis, drug resistance, and genetic testing. It also provides ST...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1999
• Employees: 576
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 137310

Financial Performance

In 2025, SD Biosensor's revenue was 710.58 billion, an increase of 2.30% compared to the previous year's 694.57 billion. Losses were -512.11 billion, 420.4% more than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 2, 2026

Data Sources Report a data error